Measuring immune response in people treated with experimental melanoma vaccine

Main Category: Melanoma / Skin Cancer
Article Date: 20 Sep 2005 - 17:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


A new study published in PLoS Medicine this week describes a way to measure the immune response in people treated with an experimental vaccine to melanoma. The technique involves monitoring how individual immune cells isolated from the patient's blood respond to the vaccine by stimulating the cells on a biological chip and looking at a range of compounds they secrete.

The most surprising finding was the very wide range of responses seen in patients' cells. Although the numbers were small - just 10 patients who had been enrolled in a trial of vaccination against melanoma - the authors were able to pick out some patterns of responses by the cells that also determined how the patient responded clinically to the vaccine. For example in patients whose tumors did not get bigger their cells secreted two particular compounds - Interferon gamma and Tumour Necrosis factor alpha.

Tumor vaccination against melanoma is being extensively investigated and several different vaccines are being assessed in early clinical trials. Unlike vaccinations against infectious diseases however, different people respond very differently to these vaccines, and so far it has not been possible to predict who will and who will not respond. This technique may provide a better way of monitoring response to treatment.

Citation: Chen DS, Soen Y, Stuge TB, Lee PP, Weber JS, et al. (2005) Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray. PLoS Med 2(10): e265.

All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere--to read, download, redistribute, include in databases, and otherwise use--subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.
http://www.plosmedicine.org

Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
plos.org

Article adapted by Medical News Today from original press release.
Visit our melanoma / skin cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christian Nordqvist. "Measuring immune response in people treated with experimental melanoma vaccine." Medical News Today. MediLexicon, Intl., 20 Sep. 2005. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/30891.php>

APA
Christian Nordqvist. (2005, September 20). "Measuring immune response in people treated with experimental melanoma vaccine." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/30891.php.

Please note: If no author information is provided, the source is cited instead.


Melanoma / Skin Cancer

Most Popular Articles



Follow Our Melanoma News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Melanoma / Skin Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »